Article

Fifth-generation femtosecond laser receives FDA clearance

Santa Ana, CA-Advanced Medical Optics (AMO) has received FDA clearance for a fifth-generation femtosecond laser (iFS).

Santa Ana, CA-Advanced Medical Optics (AMO) has received FDA clearance for a fifth-generation femtosecond laser (iFS).

Capable of creating a corneal flap during the LASIK procedure in less than 10 seconds, according to the company, the laser has an inverted bevel-in side cut angle designed to ease the flap-lifting process, increase postoperative flap adhesion, and enhance the biomechanical stability of the cornea postoperatively. When customized, it also is capable of producing an elliptical flap.

Additional features of the laser, according to the company, include a higher repetition rate; tighter spot separation; lower energy; high-resolution digital video microscope; contemporary user interface, keyboard, and touch screen; and a design meant to be ergonomic.

“The . . . laser builds upon an 8-year history of innovation and more than 2 million IntraLase femtosecond procedures performed worldwide,” said AMO Chairman and Chief Executive Officer James Mazzo, who noted that the laser is part of the company’s proprietary technology suite (iLASIK).

Perry S. Binder, MD, of the Gordon Binder Weiss Vision Institute, San Diego, said, “The new . . . laser provides the surgeon with the ability to select LASIK flap dimensions customizable to individual refractive errors and corneal anatomy.” He observed clinical trials of the laser and served as medical monitor for the technology prior to its clearance by the FDA.

The laser may be ordered now for shipment in the United States by the third quarter of this year.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.